RY 169.88 -1.0542% SHOP 144.59 -0.959% TD 77.85 -0.1667% ENB 59.62 -0.5505% BN 78.53 -0.971% TRI 223.92 -0.2495% CNQ 47.03 -0.0213% CP 102.49 -0.5627% CNR 147.77 -0.8787% BMO 131.32 -0.0685% BNS 78.4 0.0255% CSU 4463.7002 0.6222% CM 90.42 0.6344% MFC 44.91 -1.3184% ATD 77.0 -0.7604% NGT 60.01 -0.4149% TRP 68.0 -2.2989% SU 56.965 -0.4282% WCN 260.14 -0.653% L 176.45 0.7135%

Kovo Healthtech Corp

Healthcare CA KOVO

0.06CAD
0.01(33.33%)

Last update at 2024-11-20T16:48:00Z

Day Range

0.060.06
LowHigh

52 Week Range

0.010.10
LowHigh

Fundamentals

  • Previous Close 0.04
  • Market Cap5.99M
  • Volume94000
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.88300M
  • Revenue TTM10.79M
  • Revenue Per Share TTM0.19
  • Gross Profit TTM 1.48M
  • Diluted EPS TTM-0.13

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -0.91300M -2.70000M -1.19900M - -
Minority interest - - - - -
Net income -0.25000M -2.70000M -1.19900M - -
Selling general administrative 11.02M 6.55M 3.61M - -
Selling and marketing expenses - - - - -
Gross profit - - - - -
Reconciled depreciation 0.63M 0.59M 0.45M - -
Ebit - -1.25900M -1.06200M 0.35M 0.09M
Ebitda 0.46M -1.73400M -0.41600M - -
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -1.10100M -1.23200M -1.03900M - -
Other operating expenses - - - - -
Interest expense 0.74M 0.38M 0.34M 0.00000M 0.00000M
Tax provision -0.66300M - - - -
Interest income - - - - -
Net interest income -0.74000M -0.54200M -0.33800M - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 10.55M 5.90M 3.02M - -
Total operating expenses 11.65M 7.14M 4.06M - -
Cost of revenue - - - - -
Total other income expense net 0.93M -0.92600M 0.18M - -
Discontinued operations - - - - -
Net income from continuing ops -0.25000M -2.70000M -1.19900M - -
Net income applicable to common shares - -2.70000M -1.19900M 0.00900M -0.19900M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 9.26M 6.93M 7.33M 3.18M -
Intangible assets 4.34M 2.86M 2.97M 1.62M -
Earning assets - - - - -
Other current assets - - - - -
Total liab 9.56M 6.01M 7.50M 3.80M -
Total stockholder equity -0.29900M 0.92M -0.17000M -0.61400M -
Deferred long term liab - - - - -
Other current liab - - 0.96M 0.32M 0.11M
Common stock - - 4.84M 2.49M 0.00100M
Capital stock 8.79M 5.80M 4.84M 2.49M -
Retained earnings -10.94300M -6.25900M -6.00900M -3.30900M -2.11000M
Other liab - - 0.66M 0.43M -
Good will 3.97M 2.37M 2.37M 0.98M -
Other assets - - 0.19M - -
Cash 0.10M 0.69M 0.71M 0.15M -
Cash and equivalents - - - - -
Total current liabilities 6.85M 2.00M 3.47M 1.68M 1.25M
Current deferred revenue - - - - -
Net debt 5.65M 4.20M 3.56M 2.18M -
Short term debt - - - - -
Short long term debt 3.52M 1.00M 1.26M 0.74M -
Short long term debt total - - - - -
Other stockholder equity - - - - -
Property plant equipment - - 0.60M 0.13M 0.05M
Total current assets 0.67M 1.19M 1.20M 0.45M 0.13M
Long term investments - - - - -
Net tangible assets - - -5.51200M -3.21800M -2.22600M
Short term investments - - - - -
Net receivables 0.25M 0.28M 0.49M 0.29M 0.06M
Long term debt 2.23M 3.89M 3.01M 1.59M -
Inventory - - - - -
Accounts payable 3.17M 0.84M 0.99M 0.54M 0.29M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 8.59M 5.75M 6.14M 2.74M -
Capital lease obligations 0.26M 0.24M 0.62M 0.14M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.34100M -1.39600M -0.03800M - -
Change to liabilities - 0.16M 0.12M 0.00400M 0.02M
Total cashflows from investing activities - -1.39600M -0.03800M -0.12800M -0.11600M
Net borrowings - 1.20M 0.17M -0.14600M 0.17M
Total cash from financing activities 0.74M 2.95M 0.58M -0.14600M 0.17M
Change to operating activities - -0.07600M -0.07600M -0.07600M -0.07600M
Net income -0.25000M -2.70000M -1.19900M 0.00900M -0.19900M
Change in cash -0.01900M 0.56M 0.08M 0.01M 0.02M
Begin period cash flow 0.71M 0.15M 0.07M - -
End period cash flow 0.69M 0.71M 0.15M 0.07M -
Total cash from operating activities -0.42000M -1.00000M -0.46100M 0.29M -0.03400M
Issuance of capital stock 0.00000M 1.42M 0.17M - -
Depreciation 0.63M 0.45M 0.32M 0.16M 0.06M
Other cashflows from investing activities - 0.01M 0.19M 0.19M 0.19M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables -0.15500M -0.06800M -0.01500M -0.02900M 0.02M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -
Change to netincome - 1.17M 0.22M 0.14M 0.00300M
Capital expenditures 0.35M 0.16M 0.17M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.25200M -0.08000M 0.07M - -
Stock based compensation 0.48M 0.15M 0.06M - -
Other non cash items 0.27M 0.55M 0.05M - -
Free cash flow -0.76800M -1.16300M -0.62600M - -

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
KOVO
Kovo Healthtech Corp
0.01 33.33% 0.06 - - 0.56 7.48 1.27 -39.9782
RHT
Reliq Health Technologies Inc
- -% 0.21 - - 3.19 5.12 4.07 -10.7759
ADK
Diagnos Inc
- -% 0.27 - 9.75 180.09 54.61 195.86 -6.1551
NURS
Hydreight Technologies Inc
0.12 19.05% 0.75 - - 1.59 - 1.42 -1.3082
CRBK
Carebook Technologies Inc
-0.01 16.67% 0.05 - 28.57 0.57 1.14 1.23 -0.8903

Reports Covered

Stock Research & News

Profile

Kovo+ Holdings Inc. operates as a healthcare technology company. It delivers various software solutions and services, including revenue cycle management and electronic health records. The company offers its solutions to medical practices and clinics, and hospitals. The company was formerly known as Kovo HealthTech Corporation and changed its name to Kovo+ Holdings Inc. in October 2024. Kovo+ Holdings Inc. is headquartered in Vancouver, Canada.

Kovo Healthtech Corp

1600 ? 925 West Georgia Street, Vancouver, BC, Canada, V6C 3L2

Key Executives

Name Title Year Born
Mr. Gregory Noble CEO & Director 1965
Mr. Inderjit Saini CFO & Corp. Sec. 1984
Ms. Jeana K. Noble Chief Compliance Officer 1968
Ms. Jeana K. Noble President, Founder & Chief Compliance Officer 1968
Mr. Gregory Noble Founder & Director 1965
Mr. Brenner Adams Chief Executive Officer NA
Mr. Mark Detz Chief Financial Officer NA
Ms. Denise Purvis Vice President of Operations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.